What is the main objective in the development of the IB impact?

The primary objective in the development of the IB impact emphasizes biocompatibility as a critical factor. Biocompatibility ensures that the materials used in medical devices or implants do not provoke an adverse reaction in the body. This characteristic is essential when designing orthopedic devices, as the goal is to facilitate healing while integrating seamlessly into the body's biological environment. By focusing on biocompatibility, the development process aims to enhance patient outcomes, reduce inflammation, and promote a more effective healing response without complicating the body's natural processes.

While quick recovery and safer mobility, eliminating the need for casting, and biomechanical adequacy are significant considerations in the development of orthobiologics and other medical technologies, they rely on the foundational aspect of biocompatibility to be achieved effectively. In essence, without ensuring that the materials are biocompatible, the success of these other objectives could be compromised, making biocompatibility the overarching priority in the development of the IB impact.